Company news
Vivos Therapeutics, Inc. (NASDAQ:VVOS) news
Every Vivos Therapeutics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
August 25, 2026
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testin...
August 20, 2026
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
August 14, 2026
Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
August 5, 2026
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
June 30, 2026
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Commo...
June 22, 2026
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
June 11, 2026
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea a...
June 10, 2026
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
June 8, 2026
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Sup...
June 5, 2026
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
May 20, 2026
Vivos Therapeutics Reports Full Year 2025 Financial Results
April 15, 2026
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
April 15, 2026
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
April 7, 2026
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insu...
March 26, 2026
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
March 17, 2026
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep ...
February 5, 2026
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street
February 5, 2026
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
January 20, 2026
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
January 16, 2026
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
December 16, 2025
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
December 15, 2025
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
November 19, 2025
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
November 19, 2025
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
September 30, 2025
Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
September 17, 2025
Sleep Apnea Economic Burden in U.S. Exceeds $150B Annually--Vivos' Novel Solution Can Help
September 2, 2025
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
August 19, 2025
Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call
August 19, 2025
Vivos Calls Out Medical Blind Spot: OSA's Overlooked Dangerous Symptoms
August 7, 2025
Vivos Therapeutics Adds to Management Team to Support Expansion and Growth
July 30, 2025
Ignored and Undiagnosed: Sleep Apnea Threatens Women's Cognitive Health
July 22, 2025
CPAP Is Failing Patients With OCD--Vivos Exposes the Hidden Mental Health Risk
July 10, 2025
Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance
July 1, 2025
New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children
June 26, 2025
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada
June 11, 2025
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
May 15, 2025
Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call
May 14, 2025
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
April 16, 2025
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
March 31, 2025
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
March 28, 2025
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
February 24, 2025
Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.
February 18, 2025
Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 23, 2024
Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
November 14, 2024
Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
November 13, 2024
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
October 8, 2024
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
September 19, 2024
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
September 18, 2024
Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call
August 14, 2024